Valuation: Clover Corporation Limited

Market Cap 166M 117M 105M 96.98M 87.83M 164M 11.13B 1.16B 462M 5.83B 439M 429M 18.5B P/E 2027 *
12.2x
P/E 2028 * 9.8x
Enterprise Value 152M 107M 95.8M 88.57M 80.21M 150M 10.17B 1.06B 422M 5.32B 401M 392M 16.89B EV / Sales 2027 *
1.32x
EV / Sales 2028 * 1.07x
Free-Float
75.83%
Yield 2027 *
2.25%
Yield 2028 * 2.25%
1 day-0.50%
1 week-4.76%
Current month-4.31%
1 month-7.41%
3 months+6.95%
Current year+26.58%
1 week 0.98
Extreme 0.98
1.05
1 month 0.95
Extreme 0.95
1.06
Current year 0.7
Extreme 0.7
1.16
1 year 0.64
Extreme 0.64
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 2014-11-10
Director of Finance/CFO - 2021-05-05
Chief Operating Officer - 2011-02-02
Director TitleAgeSince
Director/Board Member - 2014-11-10
Chairman - 2017-09-20
Director/Board Member - 2017-01-31
Date Insider Type Main position Quantity % Market Cap. Importance
11/18/25 Sell

Chief Executive Officer

255,199 0.1528%
11/18/25 Buy

Chief Executive Officer

529,638 0.3171%
11/6/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-0.50%-4.76%+58.73%+5.26% 117M
-0.53%-0.36%+3.64%-15.03% 258B
-0.77%-1.39%+2.76%-6.23% 79.58B
+2.63%+3.64%-18.96%+14.63% 44.17B
-1.24%-2.68%+25.84%+8.13% 37.69B
-0.45%-2.41%-9.14%-11.94% 33.05B
+0.37%-1.93%+19.84%+86.14% 30.9B
-2.96%-1.85%-13.56%-10.37% 29.65B
-0.83%+1.53%-6.50%-24.54% 28.53B
-0.69%+2.21%+4.67%+6.73% 27.4B
Average -0.25%-0.96%+6.73%+5.28% 56.95B
Weighted average by Cap. -0.34%-0.49%+2.03%-3.48%

Financials

2027 *2028 *
Net sales 115M 80.92M 72.6M 67.12M 60.79M 114M 7.71B 803M 320M 4.03B 304M 297M 12.8B 132M 92.85M 83.31M 77.02M 69.76M 130M 8.84B 921M 367M 4.63B 348M 341M 14.69B
Net income 13.7M 9.64M 8.65M 8M 7.25M 13.54M 919M 95.65M 38.1M 481M 36.19M 35.43M 1.53B 17M 11.97M 10.74M 9.93M 8.99M 16.8M 1.14B 119M 47.28M 596M 44.91M 43.96M 1.89B
Net Debt -14.4M -10.14M -9.1M -8.41M -7.62M -14.23M -965M -101M -40.05M -505M -38.04M -37.24M -1.6B -24.9M -17.53M -15.73M -14.54M -13.17M -24.6M -1.67B -174M -69.24M -874M -65.78M -64.39M -2.77B
Projected Income Statement - Annual - Clover Corporation Limited
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
81
Date Price Change Volume
26-10-28 A$1.000 -0.50% 728,933
26-10-27 A$1.005 +2.03% 285,326
26-10-26 A$0.9850 -2.96% 431,332
26-10-23 A$1.015 -0.49% 251,217
26-10-22 A$1.020 -0.49% 112,483
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Clover Corporation Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.000AUD
Average target price
1.315AUD
Spread / Average Target
+31.50%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Clover Corporation Limited